| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | Director | Common Stock | 166K | $5.78M | $34.85 | Jun 20, 2025 | Direct |
| Coherus Oncology, Inc. | Director | Stock Option (Right to Buy) | 112K | Jun 12, 2025 | Direct | ||
| BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 8.43K | Jun 20, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | Jun 20, 2025 | 2 | $0 | 4 | Jun 24, 2025 | Director |
| CHRS | Coherus Oncology, Inc. | Jun 12, 2025 | 1 | $0 | 4 | Jun 13, 2025 | Director |
| BBIO | BridgeBio Pharma, Inc. | Dec 30, 2024 | 6 | $2.59M | 4 | Dec 31, 2024 | Director |
| BBIO | BridgeBio Pharma, Inc. | Jun 21, 2024 | 1 | $0 | 4 | Jun 25, 2024 | Director |
| BBIO | BridgeBio Pharma, Inc. | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| BBIO | BridgeBio Pharma, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
| BBIO | BridgeBio Pharma, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |